Literature DB >> 14713831

Selective approach for transperitoneal and extraperitoneal endoscopic nephrectomy in children.

P A Borzi1, C K Yeung.   

Abstract

PURPOSE: From the experience of a large combined series of transperitoneal (TP) and retroperitoneal (RP) endoscopic complete and partial nephroureterectomies in children, we present a logical selective endoscopic approach to benign renal pathology.
MATERIALS AND METHODS: During a 5-year period 122 complete nephrectomies and nephroureterectomies (bilateral 2, invisible ectopic 8) and 63 partial nephroureterectomies for duplex (52 upper, 8 lower) or singleton polar disease (xanthogranulomatous pyelonephritis 1, cyst 2) were performed. Of the partial nephrectomies, ureterectomy, bladder repair and lower moiety reimplantation were performed in 8. Patient age ranged from 2.7 months to 14 years (mean 2.9 years). Preoperative weight ranged from 2.7 to 98 kg (mean 12.3). The position of the renal remnant, the presence or absence of a refluxing ureter and the need for ureterectomy were the major determining factors affecting choice of endoscopic approach.
RESULTS: A total of 179 (96.7%) procedures were successfully completed endoscopically. The 6 open conversions (3.2%) occurred early in our experience. The operating time reflected the complexity of the excision and lower urinary reconstruction (lateral and posterior RP 25 to 145 minutes [mean 92]) TP with ureterocelectomy and bladder neck repair 105 to 355 minutes [mean 153]. Hospital stay for RP and simple TP was 1.5 days (mean 1 to 4) and for complicated TP 2 to 8 days (mean 3.5).
CONCLUSIONS: We suggest a posterior retroperitoneal approach with isolated renal excision without extended ureterectomy. The lateral retroperitoneal approach allows complete ureterectomy as well as better exposure to horseshoe and pelvic kidneys and, therefore, avoids exposure to intraperitoneal structures. Finally, the transperitoneal approach is recommended when complete moiety excision with lower urinary reconstruction is anticipated.

Entities:  

Mesh:

Year:  2004        PMID: 14713831     DOI: 10.1097/01.ju.0000108893.84835.e8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Laparoscopy or retroperitoneoscopy: which is the best approach in pediatric urology?

Authors:  Dimitrios Antoniou; Christos Karetsos
Journal:  Transl Pediatr       Date:  2016-10

Review 2.  [The position of laparoscopic surgery in pediatric urology].

Authors:  D Teber; S Subotic; M Schulze; C Stock; S Eskicorapci; J Rassweiler
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Laparoscopic nephrectomy for unilateral multicystic dysplastic kidney in children.

Authors:  L C Steven; A G K Li; C P Driver; A A Mahomed
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

4.  An initial experience of 100 paediatric laparoscopic nephrectomies with transperitoneal or posterior prone retroperitoneoscopic approach.

Authors:  Mohan S Gundeti; Yatin Patel; Patrick G Duffy; Peter M Cuckow; Duncan T Wilcox; Imran Mushtaq
Journal:  Pediatr Surg Int       Date:  2007-06-15       Impact factor: 1.827

5.  Current trends in pediatric minimally invasive urologic surgery.

Authors:  Dennis J Lee; Philip H Kim; Chester J Koh
Journal:  Korean J Urol       Date:  2010-02-18

6.  A two-center experience with the exclusive use of laparoscopic transperitoneal nephrectomy for benign renal disease in children.

Authors:  A A Mahomed; C Hoare; F Welsh; C P Driver
Journal:  Surg Endosc       Date:  2007-03-07       Impact factor: 4.584

7.  Outcome of laparoscopic upper pole heminephroureterectomy in children: A two-centre experience.

Authors:  Ali Serdar Gözen; Haytham Badawy; Dogu Teber; Akram Assem; Jens Rassweiler
Journal:  Arab J Urol       Date:  2016-10-11

8.  [Abdominal mass revealing xanthogranulomatous pyelonephritis in an infant].

Authors:  Anass Ayad; Badr Ettouhami; Benouachane Thami; Abdelali Bentahila
Journal:  Pan Afr Med J       Date:  2017-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.